Financing

Stock Issuance Proceeds

Zimmer Biomet Holdings Stock Issuance Proceeds increased by 623.5% to $12.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.3%, from $16.70M to $12.30M. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows a downward trend with a -24.5% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026

How to read this metric

Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.

Detailed definition

Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...

Peer comparison

Standard for large-cap companies with significant equity-based compensation programs.

Metric ID: proceeds_from_stock_issuance

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$26.20M$25.80M$5.20M$40.50M$4.50M$18.20M$14.90M$36.00M$25.10M$20.70M$19.30M$56.40M$6.60M$18.60M$500.00K$16.70M$400.00K$20.90M$1.70M$12.30M
QoQ Change-1.5%-79.8%+678.8%-88.9%+304.4%-18.1%+141.6%-30.3%-17.5%-6.8%+192.2%-88.3%+181.8%-97.3%>999%-97.6%>999%-91.9%+623.5%
YoY Change-82.8%-29.5%+186.5%-11.1%+457.8%+13.7%+29.5%+56.7%-73.7%-10.1%-97.4%-70.4%-93.9%+12.4%+240.0%-26.3%
Range$400.00K$56.40M
CAGR-14.7%
Avg YoY Growth+31.3%
Median YoY Growth-10.6%

Stock Issuance Proceeds at Other Companies

Frequently Asked Questions

What is Zimmer Biomet Holdings's stock issuance proceeds?
Zimmer Biomet Holdings (ZBH) reported stock issuance proceeds of $12.30M in Q1 2026.
How has Zimmer Biomet Holdings's stock issuance proceeds changed year-over-year?
Zimmer Biomet Holdings's stock issuance proceeds decreased by 26.3% year-over-year, from $16.70M to $12.30M.
What is the long-term trend for Zimmer Biomet Holdings's stock issuance proceeds?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's stock issuance proceeds has grown at a -24.5% compound annual growth rate (CAGR), from $122.50M to $39.70M.
What does stock issuance proceeds mean?
Cash received from the sale or issuance of company stock.